FDA-Inspected Site

Theranos, Inc.

2 FDA inspections are on record for Theranos, Inc. in Palo Alto, United States.

Clean· No action indicated

Palo Alto, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2016-08-18.

At a glance

Inspections

2

Form 483s

1

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
16 Aug 2016 – 18 Aug 2016Medical Devices & Rad HealthClean
25 Aug 2015 – 16 Sep 2015Medical Devices & Rad Health483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

16 Sep 2015
21 CFR 820.30(c)

Design input - documentation

Cited by Seema S Singh

16 Sep 2015
21 CFR 820.30(g)

Design validation - Risk analysis

Cited by Seema S Singh

16 Sep 2015
21 CFR 820.30(g)

Design validation - simulated testing

Cited by Seema S Singh

16 Sep 2015
21 CFR 820.30(g)

Design validation - user needs and intended uses

Cited by Seema S Singh

16 Sep 2015
21 CFR 820.40(a)

Document review, approval by designated individual

Cited by Seema S Singh

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.30(g)Cited across public-safe Form 483 observations3x
21 CFR 820.30(c)Cited across public-safe Form 483 observations1x
21 CFR 820.40(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Theranos, Inc.'s 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat